Gordon R L, Haskell L, Hirsch M, Shifrin E, Weinman E, Romanoff H
Cardiovasc Intervent Radiol. 1985;8(1):14-9. doi: 10.1007/BF02552634.
Transluminal dilatation of seven left subclavian arteries and one right subclavian artery was attempted in seven patients. Dilatation was successful in four left subclavian arteries and the single right subclavian artery treated. Five of the patients suffered from cerebral symptoms as well as ischemia of the upper limb, one had only cerebral symptoms and another had only arm claudication. All patients also had significantly reduced systolic blood pressures in the brachial artery. Standard techniques for percutaneous transluminal angioplasty (PTA) were employed, using the femoral route six times and the axillary route four times. No complications occurred. All patients were permanently given a maintenance dose of antiplatelet treatment with dipyridamole 75 mg tds after PTA. Follow-up of up to 36 months, indicates that angioplasty can be accomplished in the stenosed subclavian artery with relatively little hazard. Patients with hemodynamically significant stenoses should be considered for PTA if their symptoms and signs warrant such therapy.
对7例患者的7条左锁骨下动脉和1条右锁骨下动脉进行了腔内扩张术。治疗的4条左锁骨下动脉和1条右锁骨下动脉扩张成功。5例患者有脑部症状以及上肢缺血，1例仅有脑部症状，另1例仅有手臂间歇性跛行。所有患者肱动脉收缩压也显著降低。采用经皮腔内血管成形术（PTA）的标准技术，股动脉途径使用6次，腋动脉途径使用4次。未发生并发症。所有患者在PTA后均长期给予双嘧达莫75mg每日三次的维持剂量抗血小板治疗。长达36个月的随访表明，血管成形术可在狭窄的锁骨下动脉中完成，风险相对较小。如果症状和体征表明需要这种治疗，血流动力学上有显著狭窄的患者应考虑进行PTA。
